CELG


Cantor Offers Commentary On Celgene Corporation Following Acquisition Of Receptos Inc

Cantor analyst Mara Goldstein weighed in today with her views on the acquisition of Receptos Inc (NASDAQ:RCPT) by Celgene Corporation (NASDAQ:CELG) that was announced yesterday after-market close. …

A Counter Offer For Receptos Inc From Another Bidder Is Possible: Wedbush

Receptos Inc (NASDAQ:RCPT) shares rose 10 per cent in after-hours trading, following the news that Celgene Corporation (NASDAQ:CELG) intends to acquire Receptos for $232/share or $7.2 billion net …

Stock Update (NASDAQ:CELG): Celgene Corporation to Acquire Receptos Inc

Celgene Corporation (NASDAQ:CELG) and Receptos Inc (NASDAQ:RCPT) announced the signing of a definitive agreement in which Celgene has agreed to acquire Receptos. Under the …

Biotech Stock News: Oncolytics Biotech, Inc. (USA), Horizon Pharma PLC, Depomed Inc, Celgene Corporation

By Terry Chrisomalis Oncolytics Biotech, Inc. (USA) On July 6, 2015 shares of Oncolytics Biotech, Inc.

Celgene Corporation (CELG) Recommits To Cancer Collaboration With Epizyme (EPZM)

Just in front of its option deadline, Celgene Corporation (NASDAQ:CELG) has re-upped on an existing research and discovery collaboration with Epizyme Inc (NASDAQ:EPZM), a developer …

J.P. Morgan Weighs in on Juno Therapeutics Inc and Celgene Corporation Following Partnership Announcement

On June 29, Juno Therapeutics Inc (NASDAQ:JUNO) and Celgene Corporation (NASDAQ:CELG) announced a ten-year collaboration to develop new therapies for cancer and auto-immune …

Analysts Weigh in on Celgene Corporation Following Broad Deal with Juno Therapeutics Inc

Wall Street analysts are weighing today on Celgene Corporation (NASDAQ:CELG) after the pharmaceutical giant announced a 10-year broad collaboration with Juno Therapeutics Inc (NASDAQ:JUNO) to advance T-cell …

Cantor Fitzgerald Remains Positive on Celgene Corporation (CELG) Following Collaboration with Juno Therapeutics Inc (JUNO)

Cantor Fitzgerald analyst Mara Goldstein weighed in with a few of her opinions on Celgene Corporation (NASDAQ:CELG) following the company’s $1 billion collaboration with …

Celgene Corporation (CELG) Puts Up Cold Hard Cash for Access to Juno Therapeutics Inc (JUNO)’s Immunotherapies

Celgene Corporation (NASDAQ:CELG) has placed its bet in the race to develop and market T cell therapies for oncology with a $1 billion …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts